CD8A and central nervous system cancer: Additionally, they discovered human leukocyte antigen (HLA)-A*0201-restricted SOX2-derived peptides that were capable of eliciting glioma-reactive CD8+ cytotoxic T lymphocyte (CTLs) responses that could destroy glioma cells.